Clover Health Investments, Corp.
NASDAQ:CLOVMedical - Healthcare Plans
Healthcare
$3.73 +3.54%
+$0.17 today
- Market cap
- $1.98B
- Beta
- 2.48
- P/E (TTM)
- -45.6
- EPS (TTM)
- -$0.11
52W Low $1.58High $5.18
Volume 7.24M
Average 7.31M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$66.93M
FY 2025 · Annual
Investing Cash Flow
$4.08M
FY 2025 · Annual
+621.4% YoYFinancing Cash Flow
-$53.38M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (587.76M) | (339.57M) | (213.36M) | (43.01M) | (85.55M) |
| Depreciation & Amortization | 1.25M | 1.19M | 2.51M | 1.33M | 1.69M |
| Deferred Income Tax | (66.09M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 163.72M | 164.31M | 140.93M | 114.33M | 103.66M |
| Change in Working Capital | 192.67M | (2.36M) | (55.43M) | 12.86M | (84.2M) |
| Accounts Receivables | (9.39M) | (8.03M) | 0 | (6.55M) | (65.95M) |
| Inventory | 9.39M | 0 | 0 | 0 | 0 |
| Accounts Payables | 5.31M | 7.64M | 4.74M | (2.62M) | 1.65M |
| Other Working Capital | 187.37M | (1.97M) | (60.17M) | 22.03M | (19.9M) |
| Other Non-Cash Items | 13.88M | (27.49M) | 9.48M | (50.66M) | (2.53M) |
| Operating Cash Flow | (282.33M) | (203.93M) | (115.87M) | 34.85M | (66.93M) |
| Capital Expenditures | (723K) | (4.47M) | (584K) | (1.56M) | (2.04M) |
| Acquisitions (Net) | 434.72M | (16.2M) | 0 | 0 | 0 |
| Purchases of Investments | (876.25M) | (369.65M) | (175.57M) | (201.24M) | (205.1M) |
| Sales of Investments | 441.53M | 485.45M | 316.16M | 203.36M | 211.22M |
| Other Investing Activities | (434.72M) | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (435.45M) | 95.13M | 140.01M | 565K | 4.08M |
| Debt Repayment | (30.93M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 289.92M | 1.4M | 1.15M | 902K | 1.81M |
| Common Stock Repurchased | (147K) | (6.36M) | (6.22M) | (18.26M) | (55.2M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 666.55M | 0 | (28.79M) | 0 | 0 |
| Financing Cash Flow | 925.39M | (4.96M) | (33.86M) | (17.36M) | (53.38M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 207.62M | (113.76M) | (9.72M) | 18.05M | (116.24M) |
| Free Cash Flow | (283.05M) | (208.39M) | (116.46M) | 33.29M | (68.98M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$85.5M
+ D&A$1.7M
+ Stock-Based Comp$103.7M
+ Deferred Tax$0
- Working Capital-$84.2M
- Other Non-Cash-$2.5M
= Operating Cash Flow-$66.9M
- Capex-$2.0M
= Free Cash Flow-$69.0M
Analysis
FY2025 free cash flow is -$69.0M. FCF conversion is 80.6% of net income. Operating cash flow was -$66.9M, with capex of -$2.0M. The largest bridge item is Stock-Based Comp at $103.7M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 10-Q | Quarterly report | Nov 6, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 20, 2026 |
Does CLOV generate free cash flow?
Clover Health Investments, Corp. (CLOV) generated -$68.98M of free cash flow in fiscal 2025.
How much operating cash flow does CLOV produce?
Operating cash flow was -$66.93M, before capital expenditures of $2.04M.
Continue the stock analysis
Jump to another research area for this company.